- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2012
- Public Summary Document (PSD) November 2012 PBAC Meeting - PDF
Sapropterin – November 2012
Sapropterin, soluble tablet, 100 mg (as dihydrochloride), Kuvan®
Last updated
8 November 2023